Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
Springerplus|November 7, 2015
CXCL1 is elevated in the urine of bladder cancer patientsAndre Burnier, Yoshiko Shimizu, Yunfeng Dai, et al.
Oncotarget|May 28, 2016
Urinary mRNA biomarker panel for the detection of urothelial carcinomaVirginia Urquidi, Mandy Netherton, Evan Gomes-Giacoia, et al.
Diagnostics (Basel, Switzerland)|January 25, 2025
Effects of Different Voided Urine Sample Storage Time, Temperature, and Preservatives on Analysis with Multiplex Bead-Based Oncuria Bladder Cancer ImmunoassaySunao Tanaka, Kaoru Murakami, Toru Sakatani, et al.
Urology|January 31, 2004
Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumorsAshish M Kamat, Ryan P Shock, Yoshio Naya, et al.
The Journal of Urology|July 20, 2002
Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiationCharles J Rosser, Ramsay Chichakli, Lawrence B Levy, et al.
BMC Cancer|February 15, 2014
Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancerMakito Miyake, Adrienne Lawton, Yunfeng Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2011
Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantificationNa Yang, Shun Feng, Kerby Shedden, et al.
Biosensors & Bioelectronics|May 20, 2011
Paper based point-of-care testing disc for multiplex whole cell bacteria analysisChen-zhong Li, Katherine Vandenberg, Shradha Prabhulkar, et al.
BMC Cancer|May 13, 2008
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapyJohn M Pendleton, Winston W Tan, Satoshi Anai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 8, 2016
A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder CancerSijia Huang, Lei Kou, Hideki Furuya, et al.
Pageof 17